JUST IN
You are here » Home » Markets » Mutual Funds

Tata India Pharma & Healthcare Fund - Direct (G)

Fund Class : Equity - Pharma
Fund House : Tata Mutual Fund
Aum(Rs Cr) : 73.67
NAV 14 Jul 2020 12.19 -0.02
(-0.16%)

NAV High-Low (in Rs)

ONE Mth 240.98
240.98
52-WEEk 152.64
240.98

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 1.37 0.23 21.5 30.5 10.02
Sensex 1.08 10.51 -12.31 -5.6 14.68
Nifty 0.86 10.03 -12.52 -6.82 9.22

Competitors of Tata India Pharma & Healthcare Fund - Direct (G) fund

Schemes FUND
SIZE() 		1-Wk
(%)		 1-Mth
(%)		 3-Mth
(%)		 6-Mth
(%)		 1-Yr
(%)
SBI Equity Minimum Variance - Regular (G) 45.93 -0.89 4.17 17.40 -6.64 -0.12
› More

NEWS

› More

Performance Chart

See NAV History

2Y 1Y 6M 1M 5D

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 73.67 (31 Jan 16)
Inception Date 04 Dec 15
Fund Manager Meeta Shetty

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 30 Jun 2020
Category Share (%)
Equity 98.48
Reverse Repo 3.62
› More
   As On 30 Jun 2020
Sector Name Amount
Healthcare 9.01
NA 3.62
Pharmaceuticals - Indian - Bulk Drugs 18.13
Pharmaceuticals - Indian - Bulk Drugs & Formln 61.97
Pharmaceuticals - Multinational 9.37
› More
   As On 30 Jun 2020
Company Name
Sun Pharma.Inds. 17.08
Dr Reddy's Labs 16.04
Divi's Lab. 9.69
Lupin 8.44
Ipca Labs. 6.60
Cipla 6.11
Aurobindo Pharma 5.60
Proc. Gam. Heal. 4.39
› More

Fund DETAILS

Asset Management Co.

Registered Address

Tata Asset Management Ltd,

1903 B-Wing Parinee Crescenzo
G-Block Bandra Kurla Complex
Bandra East Mumbai - 400051

Phone: 6657 8282. | Fax: 2261 3782.

Email: service@tataamc.com

Website: www.tatamutualfund.com